Medica 2026
Nov 16-19, 2026 - Düsseldorf, Germany

Human Haemophilus Influenza B IgG ELISA Kit

Haemophilus influenzae type b (Hib) is a Gram-negative coccobacillus responsible for a range of serious invasive diseases, especially in young children. These conditions can include meningitis, pneumonia, epiglottitis, and bacteremia. While the Hib vaccine has dramatically reduced the global incidence of these infections, measuring antibody levels is crucial for assessing vaccine efficacy, evaluating immune response in immunocompromised individuals, and for research purposes. The Human Haemophilus Influenza B (Hib) IgG ELISA Kit is a powerful and specific in vitro diagnostic tool designed for the quantitative detection of human IgG antibodies against Hib capsular polysaccharide.

Figure 1. Toxoplasma Gondii.Figure 1. Haemophilus influenzae type b (Hib).

Key Components & Specifications

Kit Components

  • Each kit typically includes pre-coated microplates, standards, controls, enzyme conjugates, substrates, stop solutions, and wash buffers. Specific components may vary by manufacturer but generally adhere to the following:
  • Pre-coated microplate: Wells coated with purified Hib antigens (e.g., capsular polysaccharide polyribosylribitol phosphate, PRP) to capture anti-Hib IgG antibodies from samples.
  • Hib IgG Standards: Serial dilutions of purified human anti-Hib IgG with known concentrations for standard curve generation.
  • Controls: Positive and negative controls to validate assay performance (e.g., positive control: serum with confirmed high anti-Hib IgG; negative control: serum with undetectable anti-Hib IgG).
  • Enzyme Conjugate: Horseradish peroxidase (HRP)-labeled anti-human IgG antibody, which binds to captured Hib-specific IgG and catalyzes substrate reactions.
  • Substrate Solution: Chromogenic substrate that produces a color change proportional to the amount of bound enzyme.
  • Stop Solution: Acidic solution to terminate the enzyme reaction, stabilizing the color for absorbance reading.
  • Wash Buffer: Phosphate-buffered saline with Tween-20 to remove unbound components and reduce non-specific binding.

Specifications

  • Sample Type: Serum, plasma (EDTA or citrate anticoagulated), or other biological fluids (validated by manufacturer).
  • Sensitivity: Typically 0.1–0.5 μg/mL (varies by kit), ensuring detection of low antibody levels post-vaccination or mild infection.
  • Specificity: High specificity for Hib IgG, with minimal cross-reactivity to other Haemophilus strains (e.g., non-typeable H. influenzae) or unrelated pathogens.
  • Assay Range: 0.5–20 μg/mL (extendable via sample dilution).
  • Incubation Time: 2–3 hours (total assay time, including washing and detection steps).
  • Storage: Components stored at 2–8°C (or -20°C for long-term storage, per manufacturer instructions) to maintain stability.

Assay Principle

  • The kit uses a sandwich enzyme-linked immunosorbent assay (ELISA) format, leveraging antigen-antibody specificity and enzyme-mediated colorimetry:
  • Capture: Samples (or standards/controls) are added to pre-coated wells. Hib-specific IgG antibodies in the sample bind to the immobilized Hib antigens (PRP) on the well surface.
  • Washing: Unbound proteins and sample components are removed to eliminate background noise.
  • Detection: HRP-labeled anti-human IgG conjugate is added, binding to the captured Hib-specific IgG, forming a "Hib antigen-IgG-enzyme conjugate" complex.
  • Substrate Reaction: TMB substrate is added, and HRP catalyzes its conversion to a blue product. The intensity of the color is directly proportional to the concentration of Hib IgG in the sample.
  • Termination & Reading: Stop solution halts the reaction, turning the color yellow. Absorbance is measured at 450 nm (with a reference wavelength of 630 nm) using a microplate reader. A standard curve is generated from the known standards, and sample concentrations are calculated against this curve.

Sample Collection & Preparation

  • Proper sample handling is critical for accurate results:
  • Serum: Collect whole blood in serum separator tubes (SST), allow clotting at room temperature (30–60 minutes), then centrifuge at 1,000–1,500 × g for 10–15 minutes. Transfer serum to clean tubes; avoid hemolysis (red blood cell rupture can interfere with absorbance).
  • Plasma: Use EDTA or citrate as anticoagulants. Centrifuge whole blood immediately at 1,000 × g for 10 minutes to separate plasma.
  • Storage: Fresh samples are ideal, but samples can be stored at 2–8°C for up to 48 hours or frozen at -20°C (avoid repeated freeze-thaw cycles, which degrade antibodies).

Troubleshooting Common Issues

Issue

  • High background
  • Low signal in standards
  • Samples outside assay range
  • Inconsistent duplicate readings

Possible Cause

  • Inadequate washing; expired substrate
  • Incorrect conjugate dilution; improper incubation temperature
  • Over/undiluted samples
  • Uneven reagent addition; pipetting errors

Applications

  • Increase wash cycles; use fresh substrate.
  • Verify conjugate dilution; ensure 37°C incubation.
  • Re-test with adjusted dilution (e.g., 1:50 for high-titer samples).
  • Use calibrated pipettes; add reagents slowly to well centers.

The Role of Hib IgG ELISA Kits in Immune Monitoring

This is where the Human Haemophilus Influenzae B IgG ELISA Kit plays a pivotal role. Designed to quantify IgG antibodies specific to Hib in human biological samples, this kit provides a reliable, standardized method to assess immune status. IgG antibodies, which are produced by the immune system in response to infection or vaccination, persist for extended periods, making them ideal markers of long-term immunity. By measuring Hib-specific IgG levels, healthcare providers, researchers, and public health officials can evaluate vaccine efficacy, monitor population-level protection, identify individuals in need of booster doses, and support epidemiological surveillance. In essence, the Hib IgG ELISA Kit is not just a laboratory tool—it is a cornerstone of efforts to sustain the progress made against Hib and to extend that progress to underserved populations worldwide.

Data Analysis and Interpretation

The analysis of the results from the Human Hib IgG ELISA is quantitative and requires the construction of a standard curve.

Derived from Goat hosts

Standard Curve Generation

The x-axis represents the concentration of anti-Hib IgG, and the y-axis represents the absorbance.
A four-parameter logistic regression curve is the most common and accurate method for fitting the standard curve.

Derived from Goat hosts

Calculating Sample Concentrations

For each unknown sample, use its measured absorbance value and the generated standard curve to determine the corresponding anti-Hib IgG concentration.
Multiply this interpolated concentration by the sample dilution factor (e.g., 1:100) to get the final concentration in the original undiluted sample.
Concentrations are typically reported in µg/mL or mIU/mL.

Quality Control (QC) and Interpretation

Figure 1. Toxoplasma Gondii.

Human Haemophilus Influenza B IgG ELISA Kits

ParameterDetails
Product nameHuman Haemophilus Influenza B IgG ELISA Kit
SampleSerum, plasma
Intended UseHuman Haemophilus Influenza B IgG ELISA is an enzyme immunoassay for determination of IgG antibodies against polyribosylribitol phosphate of Haemophilus influenzae type B in human serum and plasma.
Species ReactivityHuman
General DescriptionHaemophilus influenzae type B (HiB) is a very common cause of invasive critical infectious diseases in children up to the age of six. Following infection the symptoms of the disease include: Pericarditis, osteomyelitis, meningitis, encephalitis, pneumonia, sinusitis and otitis. In many cases the disease is lethal or leads to neurological damage, which cannot always be prevented by rapid antibiotic therapy. The underlying reason for the disease is very often a latent immunodeficiency with a specifically reduced humoral immune response to the polyribosylribitol phosphate (PRP) in the polysaccharide encapsulation of the bacterium. In children another reason is the immaturity of the immune system. Today often the term "immunocompromised patients" is used, comprising all acquired and innate specific and unspecific immunodeficiencies.

Advantages of Human Haemophilus Influenza B IgG ELISA Kit

Fast turnaround time

Most test kits can detect results within 2-3 hours, which is faster than virus culture and on par with RIDT. This allows clinicians to make clinical decisions in a timely manner (eg. start antiviral therapy).

High Specificity and Sensitivity

The wells are pre-coated with a highly purified Hib capsular polysaccharide antigen. This ensures that only the specific anti-Hib IgG antibodies from the sample will bind, minimizing the risk of false-positive results from cross-reactive antibodies.

Efficiency and Throughput

The 96-well microplate format allows for the simultaneous processing of a large number of samples, making it highly efficient for laboratories and research studies. A single plate can accommodate standards, controls, and many patient samples.

Conclusions

The Human Haemophilus Influenzae B IgG ELISA Kit is an essential tool for monitoring immunity to Hib, supporting vaccine development, and guiding public health strategies. By providing quantitative data on anti-Hib IgG levels, it helps ensure effective protection against a pathogen that once posed a major threat to global child health. For optimal results, users should follow strict protocol adherence, validate with controls, and interpret findings in conjunction with clinical and epidemiological context.

Inquiry Basket
loading Loading ......

Inquiry

Inquiry